Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.

Pannone G, Hindi SA, Santoro A, Sanguedolce F, Rubini C, Cincione RI, De Maria S, Tortorella S, Rocchetti R, Cagiano S, Pedicillo C, Serpico R, Lo Muzio L, Bufo P.

Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1):79-88.

PMID:
21496390
[PubMed - indexed for MEDLINE]
2.

HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma.

Lo Muzio L, Leonardi R, Mariggiò MA, Mignogna MD, Rubini C, Vinella A, Pannone G, Giannetti L, Serpico R, Testa NF, De Rosa G, Staibano S.

Histol Histopathol. 2004 Jan;19(1):119-28.

PMID:
14702179
[PubMed - indexed for MEDLINE]
3.

Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.

Baba S, Hara A, Kato K, Long NK, Hatano Y, Kimura M, Okano Y, Yamada Y, Shibata T.

Oncol Rep. 2009 Nov;22(5):1173-9.

PMID:
19787237
[PubMed - indexed for MEDLINE]
4.

Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer.

Qi G, Ogawa I, Kudo Y, Miyauchi M, Siriwardena BS, Shimamoto F, Tatsuka M, Takata T.

Virchows Arch. 2007 Mar;450(3):297-302. Epub 2007 Jan 19.

PMID:
17235564
[PubMed - indexed for MEDLINE]
5.

Expression of mitotic kinases phospho-aurora A and aurora B correlates with clinical and pathological parameters in bladder neoplasms.

Bufo P, Sanguedolce F, Tortorella S, Cormio L, Carrieri G, Pannone G.

Histol Histopathol. 2010 Nov;25(11):1371-7.

PMID:
20865660
[PubMed - indexed for MEDLINE]
6.

Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation.

Chen CH, Chuang HC, Huang CC, Fang FM, Huang HY, Tsai HT, Su LJ, Shiu LY, Leu S, Chien CY.

Am J Pathol. 2013 Feb;182(2):516-28. doi: 10.1016/j.ajpath.2012.10.023. Epub 2012 Dec 3.

PMID:
23219753
[PubMed - indexed for MEDLINE]
Free Article
7.

Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients.

Vischioni B, Oudejans JJ, Vos W, Rodriguez JA, Giaccone G.

Mol Cancer Ther. 2006 Nov;5(11):2905-13.

PMID:
17121938
[PubMed - indexed for MEDLINE]
Free Article
8.

High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

Erpolat OP, Gocun PU, Akmansu M, Karakus E, Akyol G.

Strahlenther Onkol. 2012 Mar;188(3):248-54. doi: 10.1007/s00066-011-0042-7. Epub 2012 Feb 8.

PMID:
22311150
[PubMed - indexed for MEDLINE]
9.

Aurora-B protein expression is linked to initial response to taxane-based first-line chemotherapy in stage III ovarian carcinoma.

Beussel S, Hasenburg A, Bogatyreva L, Hauschke D, Werner M, Lassmann S.

J Clin Pathol. 2012 Jan;65(1):29-35. doi: 10.1136/jclinpath-2011-200212. Epub 2011 Oct 19.

PMID:
22011448
[PubMed - indexed for MEDLINE]
10.

Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.

Kurai M, Shiozawa T, Shih HC, Miyamoto T, Feng YZ, Kashima H, Suzuki A, Konishi I.

Hum Pathol. 2005 Dec;36(12):1281-8.

PMID:
16311121
[PubMed - indexed for MEDLINE]
11.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
[PubMed - indexed for MEDLINE]
12.

P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.

Lo Muzio L, Pannone G, Mignogna MD, Staibano S, Mariggiò MA, Rubini C, Procaccini M, Dolci M, Bufo P, De Rosa G, Piattelli A.

Histol Histopathol. 2004 Oct;19(4):1089-99.

PMID:
15375751
[PubMed - indexed for MEDLINE]
13.

High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.

Pukkila M, Kosunen A, Ropponen K, Virtaniemi J, Kellokoski J, Kumpulainen E, Pirinen R, Nuutinen J, Johansson R, Kosma VM.

J Clin Pathol. 2007 Mar;60(3):267-72. Epub 2006 May 26.

PMID:
16731595
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.

Chen YJ, Chen CM, Twu NF, Yen MS, Lai CR, Wu HH, Wang PH, Yuan CC.

Virchows Arch. 2009 Nov;455(5):431-40. doi: 10.1007/s00428-009-0838-3. Epub 2009 Oct 17.

PMID:
19838728
[PubMed - indexed for MEDLINE]
15.

Prognostic significance of Aurora-A expression in human bladder cancer.

Lei Y, Yan S, Ming-De L, Na L, Rui-Fa H.

Acta Histochem. 2011 Sep;113(5):514-8. doi: 10.1016/j.acthis.2010.05.004. Epub 2010 Jul 2.

PMID:
20598352
[PubMed - indexed for MEDLINE]
16.

TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.

Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M, Laimer K.

Mod Pathol. 2008 Feb;21(2):186-91. Epub 2007 Dec 14.

PMID:
18084248
[PubMed - indexed for MEDLINE]
Free Article
17.

Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.

Chen HH, Yu CH, Wang JT, Liu BY, Wang YP, Sun A, Tsai TC, Chiang CP.

Oral Oncol. 2007 Feb;43(2):122-9. Epub 2006 Jun 23.

PMID:
16798059
[PubMed - indexed for MEDLINE]
18.

Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.

Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY.

Am J Surg Pathol. 2005 Feb;29(2):167-78.

PMID:
15644773
[PubMed - indexed for MEDLINE]
19.

Prognostic value of activated Akt expression in oral squamous cell carcinoma.

Lim J, Kim JH, Paeng JY, Kim MJ, Hong SD, Lee JI, Hong SP.

J Clin Pathol. 2005 Nov;58(11):1199-205.

PMID:
16254112
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.

Kosunen A, Pirinen R, Ropponen K, Pukkila M, Kellokoski J, Virtaniemi J, Sironen R, Juhola M, Kumpulainen E, Johansson R, Nuutinen J, Kosma VM.

Oral Oncol. 2007 Jan;43(1):51-9. Epub 2006 Jun 23.

PMID:
16798062
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk